ARVN FY 2021 Earnings — Arvinas, Inc. Revenue & Financial Results | Market Cap Arena

ARVNArvinas, Inc.

$907M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$54M+106.9% YoY

Gross Profit

$54M100.0% margin

Operating Income

-$188M-351.5% margin

Net Income

-$191M-356.3% margin

EPS (Diluted)

$-3.82

Cash Flow

Operating Cash Flow

$559M

Free Cash Flow

$555M

Stock-Based Comp.

$57M

Balance Sheet

Total Assets

$1.6B

Total Liabilities

$800M

Stockholders' Equity

$782M

Cash & Equivalents

$108M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$54M	$26M	+106.9%
Gross Profit	$54M	$26M	+106.9%
Operating Income	-$188M	-$121M	-56.0%
Net Income	-$191M	-$119M	-60.1%